Fieldpoint Private Securities’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2K Sell
155
-145
-48% -$2.71K ﹤0.01% 1267
2022
Q1
$7K Buy
300
+55
+22% +$1.11K ﹤0.01% 1213
2021
Q4
$5K Buy
245
+70
+40% +$1.11K ﹤0.01% 1289
2021
Q3
$2K Hold
175
﹤0.01% 1520
2021
Q2
$3K Sell
175
-10
-5% -$168 ﹤0.01% 1352
2021
Q1
$3K Buy
185
+15
+9% +$240 ﹤0.01% 1345
2020
Q4
$2K Buy
+170
New +$2.06K ﹤0.01% 1356

Other funds holding MDRX

Fieldpoint Private Securities's MDRX Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Veradigm Inc. Common Stock (MDRX) stake by 48% in Q2 2022, selling an estimated $2.71K and leaving 155 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1267.

Fieldpoint Private Securities first reported a position in MDRX in Q4 2020 and has held it in 7 quarters since. The position peaked at $7K in Q1 2022. 246 funds tracked by Wall St. Rank hold MDRX as of Q2 2022.

  • Fieldpoint Private Securities held 155 shares of Veradigm Inc. Common Stock worth $2K as of Q2 2022.
  • Fieldpoint Private Securities sold 145 Veradigm Inc. Common Stock shares in Q2 2022, an estimated $2.71K.
  • Veradigm Inc. Common Stock made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1267 holding.
  • Fieldpoint Private Securities first reported a position in Veradigm Inc. Common Stock in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Veradigm Inc. Common Stock position peaked at $7K in Q1 2022.
  • 246 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.